Murugapandian, S. et al. 2023. Effectiveness of Casirivimab-Imdevimab and Sotrovimab Monoclonal Antibody Treatment among High-Risk Patients with Sars-Cov-2 Infection: A Real-World Experience. Archives of Clinical and Biomedical Research. 7, 3 (May 2023), 325–336.